IL-1P is known to enhance ACTH release from the anterior pituitary in the adult rat, mainly by simulating the hypothalamic ACTH-releasing hormone (CRH) release, but it seems to have a direct effect on the pituitary and on the adrenal hormone secretion, too. The effect of IL-1P on the P-endorphin (PE) secretion from the intermediate lobe is less well studied. There is very little information on the effect of IL-1P on the hypothalamic-pituitaryadrenal axis (HPAA) in the postnatal rat, which is a special period, because the reactivity of the HPAA is blunted. The effect of IL-1P in this period seemed to be of special interest, because neither the immune nor the endocrine system is fully developed.
IL-1P is known to enhance ACTH release from the anterior pituitary in the adult rat, mainly by simulating the hypothalamic ACTH-releasing hormone (CRH) release, but it seems to have a direct effect on the pituitary and on the adrenal hormone secretion, too. The effect of IL-1P on the P-endorphin (PE) secretion from the intermediate lobe is less well studied. There is very little information on the effect of IL-1P on the hypothalamic-pituitaryadrenal axis (HPAA) in the postnatal rat, which is a special period, because the reactivity of the HPAA is blunted. The effect of IL-1P in this period seemed to be of special interest, because neither the immune nor the endocrine system is fully developed.
In the present study we tested the 30-and 120-min effect of intraperitoneally administered 0.5 and 100 ng/g body weight IL-1P on the plasma immunoreactive (ir) ACTH, PE, and corticosterone (CS) levels in the 10-d-old (infant) and 30-d-old (prepubertal) rat. Generally, the ir-ACTH, ir-PE, and ir-CS levels were significantly higher in prepubertal than in infant rats. Hormone levels were more enhanced by the higher dose of IL-1P, and changes were more pronounced at 120 min than at 30 min. The relative increase of ir-ACTH and ir-PE was smaller in the infant than in the prepubertal rat. In contrast, the relative increase of ir-CS was more pronounced in the infant rat. Changes in plasma ir-PE and ir-ACTH levels were not parallel, suggesting different responsiveness of the anterior pituitary corticotrophs and intermediate pituitary melanotrophs to IL-1P stimulation. The age-related peculiarities in response to IL-1P could be due to a different secretory capacity and/or different kinetics of the HPAA in the infant (10-d-old) and prepubertal (30-d-old) rat. There could be a change in sensitivity of different components of the HPAA (hypothalamus, pituitary, adrenal) to IL-1P during the postnatal development. (Pediatr Res 37: 714-719, 1995) Abbreviations CRH, ACTH-releasing factor PE, P-endorphin CS, corticosterone ir, immunoreactive HPAA, hypothalamic-pituitary-adrenal axis i.p., intraperitoneally IL-1P is a 17,500-D hormone-like polypeptide synthesized and released predominantly by macrophages and monocytes. It acts as a primary mediator in the acute phase of the response to microbial infection and physical stressors (1, 2) . In addition to its role in the host defense mechanism, a growing body of evidence has accumulated indicating that IL-1P is a putative mediator between the immune and neuroendocrine systems (3) (4) (5) (6) (7) (8) (9) (10) . Interactions between the immune system and the HPAA are of particular interest, because they are both associated in the adaptive response to stress. The main target of the IL-1P effect on the HPAA is believed to be the stimulation of C R H secretion (11-13), but it has been shown to exert a direct effect on the pituitary and on adrenal hormone secretion as well (14, 15) . It is to be elucidated if activation of the HPAA by IL-1P is a specific effect or if it represents a nonspecific stress reaction.
In the neonatal rat responsiveness of the HPAA to stressful stimuli is reduced. During this stress-hyporesponsive period, the ACTH response to a variety of nonspecific stressors as ether inhalation or electroshock (16, 17) , hypoglycemia (18) , histamine, and cold (19) is blunted. Additionally, after cold or ether stress plasma PE levels were unchanged in the 10-d-old but enhanced in older rats (20) . In contrast, plasma PE levels of the 10-d-old rats were considerably increased after the specific stimulus of an opiate anesthetic (21) .
Whereas the effect of IL-1P on the HPAA in the adult rat is extensively studied, w e are aware of only one study on the effect of IL-1P on the HPAA of the prepubertal rat; the HPAA HPAA REACTIVITY TO IL-1P IN INFANT RAT 715 reactivity of the infant rat (less than 20 d old) has not been studied. In addition we do not know of any data testing the effect of IL-1P on plasma ir-ACTH, ir-CS, and ir-PE levels simultaneously, neither in adult nor in infant or in prepubertal rats. In a recent study (22) a dose-dependent elevation in plasma ACTH and CS concentrations was found in immature (21-22 d old) rats after 0.5-2.0 ng/g IL-1P i.p. Inasmuch as IL-1P is considered as a specific mediator between the immune system and the HPAA (8-lo), the comparison of the effect of IL-1P on the activity of HPAA in the 10-d-old (infant) and in the 30-d-old prepubertal (postweaning) rat could discriminate between the possible specific and nonspecific component of the activation of the HPAA by IL-1P.
METHODS

Animals.
Wistar rats of our inbred colony were kept under standard laboratory conditions: 12-12-h light-dark cycle, 23 + 2°C room temperature, commercial rat food, and fresh tap water ad libitum. They were bred in pairs, and the morning on which pups were found in the cage was considered the first postnatal day. Litter size was reduced to 10, and the pups were weaned on the 22nd postnatal day. The 10-d-old pups of either sex were left with the parent rats until the end of the experiment. The 30-d-old male rats, kept three per cage, were handled daily for 1 wk before the experiment. Both 10-and 30-d-old rats were weighed and labeled the day before the experiment.
Experimental design. Both in the 10-and in the 30-d-old rats the effect of 0.5 and 100 nglg body weight11 p L IL-1P was tested 30 and 120 rnin after i.p. injection. Untreated rats, subjected to handling, and saline-treated rats (physiologic saline, 1 pL/g body weight i.p.) corresponding to the time schedule of the given experiment served as controls. In one experiment the response to one dose of IL-1j3 (0.5 or 100 ng/g body weight) at one time point (30 or 120 min) was tested either in 10-or in 30-d-old rats with the corresponding control groups. Experiments were performed between 0900 and 1100 h. Treatments were given according to a randomized block design using 50-or 100-pL Hamilton syringes. After injection, rats were returned immediately to their mother or their home cage, respectively. ZL-1/3. The human recombinant IL-1P we used in this study was expressed in the Escherichia coli strain JM 103 as soluble protein. The expression vector (human macrophage origin cDNA coding the sequence of IL-1P cloned into the M7111 vector) was a generous gift of Prof. T. BBrtfai (University of Stockholm, Sweden). The crude IL-1P extract was further purified to homogeneity according to Wingfield et al. (23) . The specific bioactivity determined by the thymocyte-activating factor assay was 1.4 X lo7 UImL, and the endotoxin contamination detected by the Limulus amebocyte lysate chromogenic assay was less than 0.75 endoxin unit/mL.
Sample collection and hormone measurements. Thirty or 120 min after the treatments, animals were decapitated, and the trunk blood was collected on ice into Eppendorf tubes containing an appropriate volume of 20% K,-EDTA. Blood was centrifuged and stored at -20°C until assayed. Plasma hormone levels (ir-ACTH, ir-PE, and ir-CS) were determined by RIA without extraction as described previously (21, 24) . The ACTH antibody was used in 1:150,000 final dilution, total bound was 30%, nonspecific binding 1.7%, and the ED,, 1.5 fmol ACTHJtube. Final dilution of the ir-PE antibody was 1:120,000, the total bound was 30%, nonspecific binding 1.7%, the ED,, 5.8 fmol PEltube. In our CS RIA (final antibody dilution 1:8000) total bound was 45%, nonspecific binding 14% and ED,, 1 pmol CSItube. The coefficient of variation for ACTH, PE, and CS RIA was 10.5 + 1.44, 8.51 + 1.18 and 15.33 t 2.34, (n = 30), respectively.
Statistical evaluation. Inasmuch as the Bartlett test revealed no homoscedasticity between any of the experimental groups for any hormones, the nonparametric Kruskal-Wallis test with painvise comparisons was applied using the Crunch statistical computer program. In the tables, the only differences between experimental groups of the same experiment (i.e. one dose in one time) are shown. Table I ). The mean plasma ir-ACTH levels of the untreated 30-d-old rats from the four experiments were higher than that of the untreated 10-d-old pups (86.0 f 6.17 pmolIL, n = 36 versus 19.0 t 1.05 pmol/L, n = 36; p < 0.0001).
RESULTS
ACTH (
Injection of 0.5 ng/g IL-1P to 10-d-old rats increased plasma ir-ACTH levels at 120 rnin but not at 30 rnin when compared with the saline-treated animals, whereas in the 30-d-old rats elevated hormone levels were seen at both times. Administration of 100 ng/g IL-1P produced significant increase of the plasma ir-ACTH level in both ages and in both time points tested. The relative elevation of plasma ir-ACTH after IL-1P was always higher in the prepubertal than in the infant rats when compared with the untreated rats. This tendency was also seen relative to the saline-treated group except for 30 min after the higher IL-1P dose (100 ng/g). /3E ( Table 2 ). Similar differences to the ir-ACTH levels were seen in plasma ir-/3E levels of the untreated 10-and 30-d-old rats (52.7 + 2.76 pmol/L, n = 36 versus 96.5 + 8.85 pmol/L, n = 36; p < 0.0001). The lower dose of IL-1P (0.5 ng/g) affected the ir-PE levels neither in the 10-d-old nor in the 30-d-old rats 30 min after injection, whereas 120 min later significant elevation was seen only in the 10-d-old pups. Injection of 100 ng/g IL-1P elicited significant elevations in the plasma ir-PE levels in rats of both age, the elevation being higher at 120 min than after 30 min. The 120-min increase in plasma ir-PE relative to the saline-treated group was more pronounced in the 30-d-old animals (432%) than in the 10-dold pups (251%).
CS (Table 3) . The difference between plasma CS levels of untreated 10-and 30-d-old rats exceeded that seen for ir-ACTH, being about two orders of magnitude higher in the prepubertal than in the infant rats (456.3 ? 54.4 nmol/L, n = 36 versus 4.2 t 1.12 nmol/L, n = 36; p < 0.0001). In the 10-d-old pups plasma ir-CS increased 120 rnin but not 30 min after 0.5 ng/g IL-lP, whereas the high dose (100 ng/g) of IL-1P increased plasma ir-CS at both times. In the 30-d-old rats 
Values are mean + SEM with number of determinations in parentheses; IL-lp, the dose of IL-1p (ngig b.w. i.p.); t,,,,,, the time between treatment and decapitation (rnin). 
DISCUSSION
In the present work, plasma ir-ACTH, ir-PE, and ir-CS levels were measured in the 10-(infant) and 30-d-old (prepubertal) rats after i.p. injection of IL-1P. When comparing the basal hormone levels of the 10-and the 30-d-old rats, the levels of ir-ACTH (Table 1) and of ir-PE levels (Table 2) were higher in the prepubertal than in the infant rats. For the ir-CS levels this difference was more striking (Table 3) , although the plasma ir-ACTH concentrations of the same rats did not reflect stressed values (86.0 + 6.17 pmol/L). This could be explained by the enhanced sensitivity of the adrenal gland of the prepubertal rats to the circulating ACTH or to experimental manipulations. This is in agreement with previous findings when ir-PE (20) and ir-CS (20, 25) concentrations in the plasma of the 10-and 22-d-old rats were compared. Inasmuch as we paid special attention to keeping maternal deprivation very short (maximum 30 s) during the experiment, the ir-CS levels of the infant rats were very low, reflecting the basal activity of the HPAA (Table 3 ). There was a tendency for slightly elevated hormone levels after i.p. saline injection, but significant change was seen only in few cases.
Elevation in plasma ir-ACTH levels after the low dose of IL-1P (0.5 nglg) at 30 rnin was seen only in the 30-d-old rats. The rise in plasma ir-ACTH levels 120 min after the injection of 0.5 ng/g IL-1P was comparable in the 10-d-old pups and in the 30-d-old rats (189 and 248%, respectively). Interestingly, 30 min after injection of the higher dose of IL-1P (100 ng/g), the relative increase in plasma ACTH level was higher in the 10-than in the 30-d-old rats (666 versus 380%), although higher absolute values were seen in the latter group. In contrast, 120 min after the injection a larger increase was seen in the prepubertal than in the infant rats (1855 versus 866%). These findings are in contrast with those of Witek-Janusek (25) who by injecting a 90% lethal dose of endotoxin found no difference in basal and stimulated plasma ACTH levels of the 10-and 21-d-old rats. It is known that the activation of HPAA by endotoxins is mediated by cytokines such as IL-1, tumor necrosis factor-a, and IL-6, which are released from immunoreactive cells and affect the brain (for review, see Ref. 26) . It may be supposed that the complexity of the reaction to endotoxin is fully developed by d 10, but the maturation of the sensitivity of the HPAA to IL-1P is delayed.
In the 10-d-old rats changes in plasma ir-PE levels showed similar pattern to that seen for ir-ACTH after both dose of IL-1P, but the relative ir-PE increase was generally smaller than that of the ir-ACTH, especially at 120 min. These differences were more expressed in the 30-d-old rats, as only the high (100 ng/g) dose of IL-1P affected plasma ir-PE levels.
Changes in the plasma ir-CS concentrations in the 10-d-old rats resembled that of the ir-ACTH levels, but the 120-min relative increase was considerably higher than for ir-ACTH. In contrast, in the 30-d-old rats plasma ir-CS was not elevated every time when ir-ACTH was high (i.e. 30 min after IL-1P) and the relative increase for ir-CS 120 min after 100 ng/g BARNA ET AL.
IL-1P was lower than for ir-ACTH. These results indicate a more susceptible adrenal response of the infant rats to IL-1P. This again could be an indication of the higher responsiveness of the adrenal either to the circulating ir-ACTH or to the possible direct effect of IL-1P on the adrenal hormone secretion (15) .
Earlier studies reported dose-and time-related elevations in plasma ACTH, CS, and catecholamine concentrations after i.v. as well as intracerebroventricular IL-1P administration in adult rats (8) (9) (10) . IL-1P is believed to stimulate either directly or indirectly the secretion of hypothalamic CRH (11) (12) (13) known to predominate in the control of pituitary corticotrophs. Intrahypothalamic IL-1P infusion as well as microlesions in the rat brain demonstrated the importance of certain brain structures (organum vasculosum of lamina terminalis, preoptic area, paraventricular nucleus) in the IL-induced stimulation of the HPAA (27, 28) . Certain neurones in the preoptic nucleus have receptors to which the cytokines bind (for review, see Ref. 26) . The preoptic neurones communicate with another hypothalamic nucleus, the paraventricular nucleus, which contains neurones that release CRH.
When injected i.v., 0.5 nglg IL-1P produced an extremely high plasma ACTH response in adult rats 15 min after administration (10). In our hands i .~. iniection of the same dose had HPAA of the adult rat, but its effect in the infant rat has not been studied before. The finding that the changes in plasma ACTH levels were more pronounced in the 30-than in the 10-d-old rats ( Table 1 ) may indicate that in infant rats the pituitary ACTH secretory response to IL-1P is weaker compared with the reactivity in later age. This finding could be explained by the stress-hyporesponsive state of these animals, by the different kinetics of the HPAA activation in the infant and in the adult rats, or by a specific neuroendocrine effect of IL-1P. IL-1P administration-induced relative changes in plasma CS levels were more pronounced in the 10-than in the 30-d-old rats. This finding together with the distinct pattern of ir-ACTH and of ir-PE changes may indicate that, in the infant and in the prepubertal rats, IL-1P activates the HPAA as a specific, receptor-mediated stimulus and not by eliciting a nonspecific stress reaction.
